CR Intrinsic Investors’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-20,000
Closed -$458K 268
2013
Q3
$458K Buy
+20,000
New +$458K 0.01% 305